Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Avid Bioservices, Inc. Common Stock

Avid Bioservices is a drug substance CDMO that offers full lifecycle capabilities, providing services from concept to commercial supply in mammalian cell culture for clinical and commercial biologics.

COM:AVIDBIO

Avid Bioservices

Last Close

11.61

25/09 14:39

Market Cap

678.14M

Beta: -

Volume Today

169.56K

Avg: -

People Not Available